Literature DB >> 18984011

Individual differences to repeated ethanol administration may predict locomotor response to other drugs, and vice versa.

Karina Possa Abrahao1, Isabel Marian Hartmann Quadros, Maria Lucia Oliveira Souza-Formigoni.   

Abstract

Repeated administration of drugs may induce adaptations which affect the behavioral responses to the drug itself or to other drugs. Whether individual characteristics to repeated drug administration predict sensitivity to the effects of another drug is not clear. We evaluated whether or not mice that present higher vs. lower locomotor response after repeated treatment with ethanol display increased or decreased locomotor responses when challenged with methamphetamine or morphine, and vice versa. Mice received daily i.p. 2.2 g/kg ethanol (21 days), 1.0 mg/kg methamphetamine or 10 mg/kg morphine (10 days). According to the response presented during repeated drug treatment, mice were classified as HIGH or LOW activity groups. Locomotor activity was monitored after mice were challenged with saline, and 48 h later with a drug. Ethanol-treated mice were challenged with methamphetamine or morphine, methamphetamine- and morphine-treated animals were challenged with ethanol. After repeated treatment with ethanol or methamphetamine, locomotor sensitization was observed only in HIGH mice, not LOW mice. Ethanol-treated mice with HIGH activity showed sensitized, increased locomotor responses to methamphetamine (p<0.05), but not to morphine. Locomotor responses to ethanol were not affected by a previous history of methamphetamine treatment. Although repeated administration of morphine failed to induce sensitization, morphine-treated mice with HIGH activity presented sensitized locomotor responses after an ethanol challenge. The current experiments confirm important individual differences in response to repeated administration of ethanol, methamphetamine and morphine, which in some cases affected the locomotor response to a second drug challenge, in an asymmetrical pattern.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984011     DOI: 10.1016/j.bbr.2008.10.009

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  A history of ethanol drinking increases locomotor stimulation and blunts enhancement of dendritic dopamine transmission by methamphetamine.

Authors:  Christopher W Tschumi; Anna W Daszkowski; Amanda L Sharpe; Marta Trzeciak; Michael J Beckstead
Journal:  Addict Biol       Date:  2019-05-06       Impact factor: 4.280

2.  Locomotor sensitization to ethanol impairs NMDA receptor-dependent synaptic plasticity in the nucleus accumbens and increases ethanol self-administration.

Authors:  Karina Possa Abrahao; Olusegun J Ariwodola; Tracy R Butler; Andrew R Rau; Mary Jane Skelly; Eugenia Carter; Nancy P Alexander; Brian A McCool; Maria Lucia O Souza-Formigoni; Jeffrey L Weiner
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

Review 3.  Combined and sequential effects of alcohol and methamphetamine in animal models.

Authors:  Alexandra M Stafford; Bryan K Yamamoto; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2021-09-17       Impact factor: 8.989

4.  Consequence of Two Protocols of Social Defeat Stress on Nicotine-Induced Psychomotor Effects in Mice.

Authors:  Liz Paola Domingues; Bruno de Brito Antonio; Maria Gabriela Menezes de Oliveira; Isabel Marian Hartmann de Quadros
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

5.  Long-term exposure to daily ethanol injections in DBA/2J and Swiss mice: Lessons for the interpretation of ethanol sensitization.

Authors:  Vincent Didone; Théo van Ingelgom; Ezio Tirelli; Etienne Quertemont
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

6.  Individual differences in ethanol locomotor sensitization are associated with dopamine D1 receptor intra-cellular signaling of DARPP-32 in the nucleus accumbens.

Authors:  Karina Possa Abrahao; Francine Oliveira Goeldner; Maria Lucia Oliveira Souza-Formigoni
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.